Document:

ALPINE
        ALPHA 2, LTD

      SUBSCRIPTION
        AGREEMENT

      

      This
        will
        acknowledge that the undersigned hereby agrees to purchase _______ shares
        of
        common stock, par value $0.001, of Alpine Alpha 2, Ltd (the “Company”) at $_____
        per share for a total of $____. The undersigned acknowledges that the shares
        of
        common stock have not been registered under the Securities Act of 1933, as
        amended, and that the securities received by the undersigned will bear a
        legend
        indicating the transfer of such securities shall be restricted by reason
        of the
        fact that such securities have not been so registered.

      

      The
        undersigned represents that he/she is acquiring the shares for his/her own
        account for investment purposes only and not with a view to resell or distribute
        thereof, nor with the intention of selling, transferring or otherwise disposing
        of all or any part of such shares for any particular price or at any particular
        time or upon happening of any particular event or circumstances, except selling,
        transferring or disposing of the shares made upon full compliance with the
        applicable provisions of the Securities Act of 1933 and the Securities and
        Exchange of Act of 1934 and the rules and regulations promulgated by the
        Securities and Exchange Commission thereunder; and that such shares must
        be held
        indefinitely unless they are subsequently registered under the Securities
        Act of
        1933 or an exemption from registration is available, and that any routine
        sales
        of securities made in reliance of Rule 144 can be made only in limited amounts
        and in accordance with the terms and conditions of that Rule.

      

      The
        undersigned also acknowledges that he/she has received the following information
        in connection with the purchase of the aforementioned shares of the Company,
        and
        no other representation, statement or inducements were made to cause him/her
        to
        purchase these securities.

      

      1.
        The
        Company was duly organized under the laws of the State of Delaware on October
        29, 2007. 

      

      2.
        The
        certificate of incorporation authorized capitalization of 50,000,000 common
        shares at 0.001 par value per share. 

       

      3.
        The
        Company is a development stage company with limited activities and limited
        assets. The Company operates in the industrialization and modernization of
        Chinese companies. 

      

      4.
        No
        commission will be paid to anyone to sell the shares.

      

      5.
        There
        is no public market for the Company’s securities, nor can the Company guarantee
        that a public market will develop in the near future, if at all.

      

      6.
        None
        of the securities to be sold herein have been registered with the Securities
        and
        Exchange Commission or with the securities division of any state, nor has
        any
        regulatory agency passed upon the merits of the securities or upon the accuracy
        of any information contained herein or in any document. 

      

      7.
        The
        undersigned has been apprised of the fact that the Company will register
        to do
        business in the State of Delaware but the Company cannot guarantee that it
        will
        register to do business in any other state in the future. 

      

      8.
        In
        connection with the purchase of these shares, the undersigned also acknowledges
        that:

      

      (a)
        I
        have not received any general solicitation of general advertising regarding
        the
        purchase of these securities.

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      (b)
        I
        have sufficient knowledge and experience of financial and business matter
        so
        that I am able to evaluate the merits and risks of purchasing the shares,
        and I
        have had substantial experience in previous private and public purchases
        of
        securities.

      

      (c)
        I
        have adequate means to provide for my personal needs, possess the ability
        to
        bear the economic risk of holding the shares purchased hereunder indefinitely,
        and can afford a complete loss on the purchase of these securities.

      

      (d)
        During the transaction and prior to purchase, I have read this Subscription
        Agreement and have full opportunity to ask questions of and receive answers
        from
        the Company and its founders and officers, and to receive such information
        contained herein or any additional information requested. I do not desire
        to
        receive any further information. However, my decision to purchase shares
        from
        the Company is based entirely and solely upon the information provided by
        Alpine
        Alpha 2, Ltd. 

      

      (e)
        I
        understand the meaning of the first two paragraphs of this Subscription
        Agreement, and that a restrictive legend will be placed on the shares purchased
        hereunder, and that instructions will be placed with the Transfer Agent for
        the
        Company’s securities prohibiting the transfer of my securities purchased
        hereunder absent full compliance with the Securities Act of 1933 and the
        Securities and Exchange Act of 1934.

      

      NEW
        YORK RESIDENTS

       

      THE
        ATTORNEY GENERAL OF THE STATE OF NEW YORK DOES NOT PASS UPON OR ENDORSE THE
        MERITS OF ANY PRIVATE OFFERING. NO OFFERING DOCUMENT HAS BEEN FILED WITH
        OR
        OTHERWISE APPROVED BY THE DEPARTMENT OF SECURITIES OR THE DEPARTMENT OF LAW
        AND
        PUBLIC SAFETY OF THE STATE OF NEW YORK. ANY REPRESENTATION TO THE CONTRARY
        IS
        UNLAWFUL.

      

      I
        hereby
        subscribe to the shares set forth on page one (1) of this Subscription
        Agreement, and am tendering herewith my check for the full amount of my
        subscription, made payable to the order of Alpine
        Alpha 2, Ltd and am mailing same to Alpine Alpha 2, Ltd, PO Box 735, New
        Jersey
        07620, USA.

      

      $
        _________ at $________ per share for __________ common shares

      

      Dated:
        ____________, 2008

      

      AGREED
        AND ACKNOWLEDGED

       

      Name:
        __________________

      

      By:_________________________________

      (signature)

       

      Complete
        Address: _____________________  

      City,
        State:  _____________________

      Fax
        or
        Email:  ___________________ Phone
        No.:  _________

      

      Identification
        Number: _______________________

      USA,
        Social Security Number:  __________________Unassociated Document

    FORM
      OF COMMON STOCK PURCHASE WARRANT

    

    

    To
      Purchase __________ Shares of Common Stock of

     

    HUIHENG
      MEDICAL, INC.

     

    UNDER
      NASD RULE 2710(g) AND SUBJECT TO LIMITED EXCEPTIONS, THIS WARRANT AND THE
      UNDERLYING SHARES OF COMMON STOCK SHALL NOT BE SOLD DURING THE PUBLIC OFFERING,
      AS HEREIN DEFINED, OR SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED,
      OR
      BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION
      THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS WARRANT OR
      THE
      SECURITIES UNDERLYING THIS WARRANT BY ANY PERSON FOR A PERIOD OF 180 DAYS
      IMMEDIATELY FOLLOWING THE DATE OF EFFECTIVENESS OR COMMENCEMENT OF SALES OF
      THE
      PUBLIC OFFERING.

    

    THIS
      COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, _________
      (the
“Holder”),
      is
      entitled, upon the terms and subject to the limitations on exercise and the
      conditions hereinafter set forth, at any time on or after _______ __, 2008
      (the “Initial
      Exercise Date”)
      and on
      or prior to the close of business on _______ __, 2013 (the “Termination
      Date”)
      but
      not thereafter, to subscribe for and purchase from Huiheng Medical, Inc., a
      corporation incorporated in the State of Nevada (the “Company”),
      up to
      ________ shares (the “Warrant
      Shares”)
      of
      Common Stock, par value $0.001 per share, of the Company (the “Common
      Stock”).
      The
      purchase price of one share of Common Stock (the “Exercise
      Price”)
      under
      this Warrant shall be $________
      (115%
      of
      the initial public offering (“Offering”)
      price
      per share of Common Stock registered under the registration statement on Form
      SB-2, as amended on Form S-1 (No. 333-146975) (the “Registration
      Statement”)),
      subject to adjustment hereunder. 

     

    1. Title
      to Warrant.
      Prior
      to the Termination Date and subject to the transfer restrictions imposed by
      NASD
      Rule 2710(g) as set forth in the legend hereto, this Warrant and all rights
      hereunder are transferable, in whole or in part, at the office or agency of
      the
      Company by the Holder in person or by duly authorized attorney, upon surrender
      of this Warrant together with the Assignment Form annexed hereto properly
      endorsed.

     

    2. Authorization
      of Shares.
      The
      Company covenants that all Warrant Shares which may be issued upon the exercise
      of the purchase rights represented by this Warrant will, upon exercise of the
      purchase rights represented by this Warrant, be duly authorized, validly issued,
      fully paid and nonassessable and free from all taxes, liens and charges in
      respect of the issue thereof (other than taxes in respect of any transfer
      occurring contemporaneously with such issue).

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    3. Exercise
      of Warrant.
      

     

    (a)
      Except as provided in Section 4 herein, exercise of the purchase rights
      represented by this Warrant may be made at any time or times on or after the
      Initial Exercise Date and on or before the Termination Date by the surrender
      of
      this Warrant and the Notice of Exercise Form annexed hereto duly executed,
      at
      the office of the Company (or such other office or agency of the Company as
      it
      may designate by notice in writing to the registered Holder at the address
      of
      such Holder appearing on the books of the Company) and upon payment of the
      Exercise Price of the shares thereby purchased by wire transfer or cashier’s
      check drawn on a United States bank or by means of a “cashless exercise”
pursuant to Section 3(c), the Holder shall be entitled to receive a certificate
      for the number of Warrant Shares so purchased. Warrant Shares purchased
      hereunder shall be delivered to the Holder within three (3) business days after
      the date on which this Warrant shall have been exercised as aforesaid. This
      Warrant has been or will be registered on the Registration Statement and
      accordingly, if this Warrant is exercised at a time when the Registration
      Statement (or any registration statement registering the sale of the Warrant
      Shares to the Holder upon exercise of this Warrant) is then effective and
      available for use or if this Warrant is exercised by means of a “cashless
      exercise” pursuant to Section 3(c) after ______, 2009 (such condition each a
“Condition”),
      the
      Company shall deliver the Warrant Shares to the Holder, if eligible, via the
      Depository Trust Company’s (“DTC”)
      Deposit Withdrawal Agent Commission (“DWAC”)
      system
      via the DTC instructions provided to the Company in the Notice of Exercise.
      If
      either Condition is met at the time of exercise, the Warrant Shares shall be,
      when issued, unlegended and free of any resale restrictions. If no Conditions
      are met at the time of such exercise, the certificates representing the Warrant
      Shares shall be issued in paper form and contain a standard Securities Act
      legend restricting resale without registration or an exemption. This Warrant
      shall be deemed to have been exercised and such certificate or certificates
      shall be deemed to have been issued, and the Holder or any other person so
      designated to be named therein shall be deemed to have become a holder of record
      of such shares for all purposes, as of the date the Warrant has been exercised
      by payment to the Company of the Exercise Price and all taxes required to be
      paid by the Holder, if any, pursuant to Section 5 prior to the issuance of
      such
      shares, have been paid. 

    

    (b) If
      this
      Warrant shall have been exercised in part, the Company shall, at the time of
      delivery of the certificate or certificates representing Warrant Shares, deliver
      to Holder a new Warrant evidencing the rights of Holder to purchase the
      unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
      in all other respects be identical with this Warrant.

     

    (c)
      If,
      but only if, at any time after the Initial Exercise Date the Registration
      Statement (or a registration statement registering the sale of the Warrant
      Shares to the Holder upon exercise of this Warrant) is not then effective or
      unavailable for use as reasonably determined by the Company such that the
      Company is unable to otherwise issue the Warrant Shares unlegended and free
      of
      any resale restrictions at such time, this Warrant may also be exercised at
      such
      time by means of a “cashless exercise” in which the Holder shall be entitled to
      receive a certificate for the number of Warrant Shares equal to the quotient
      obtained by dividing [(A-B) (X)] by (A), where:

     

    (A)
      = the
      VWAP on the Trading Day preceding the date of such election;

    

    (B)
      = the
      Exercise Price of the Warrant, as adjusted; and 

    

    (X)
      = the
      number of Warrant Shares issuable upon exercise of the Warrants in accordance
      with the terms of this Warrant.

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    “VWAP”
means,
      for any date, the price determined by the first of the following clauses that
      applies: (a) the daily volume weighted average price of the Common Stock for
      such date (or the nearest preceding date) on the primary market or exchange
      on
      which the Common Stock is then listed or quoted as reported by Bloomberg
      Financial L.P. (based on a Trading Day from 9:30 a.m. Eastern Time to 4:02
      p.m.
      Eastern Time); (b) if the Common Stock is not then listed or quoted on a
      market or exchange and if prices for the Common Stock are then quoted on the
      OTC
      Bulletin Board, the volume weighted average price of the Common Stock for such
      date (or the nearest preceding date) on the OTC Bulletin Board; (c)  if the
      Common Stock is not then listed or quoted on the OTC Bulletin Board and if
      prices for the Common Stock are then reported in the “Pink Sheets” published by
      the National Quotation Bureau Incorporated (or a similar organization or agency
      succeeding to its functions of reporting prices), the average of the most recent
      bid and ask price per share of the Common Stock so reported; or (d) in all
      other cases, the fair market value of a share of Common Stock as determined
      by a
      nationally recognized-independent appraiser selected in good faith by
      Holder.

    

    4. No
      Fractional Shares or Scrip.
      No
      fractional shares or scrip representing fractional shares shall be issued upon
      the exercise of this Warrant. As to any fraction of a share which Holder would
      otherwise be entitled to purchase upon such exercise, the Company shall pay
      a
      cash adjustment in respect of such final fraction in an amount equal to such
      fraction multiplied by the Exercise Price.

     

    5. Charges,
      Taxes and Expenses.
      Issuance of certificates for Warrant Shares shall be made without charge to
      the
      Holder for any issue or transfer tax or other incidental expense in respect
      of
      the issuance of such certificate, all of which taxes and expenses shall be
      paid
      by the Company, and such certificates shall be issued in the name of the Holder
      or in such name or names as may be directed by the Holder; provided,
      however,
      that in
      the event certificates for Warrant Shares are to be issued in a name other
      than
      the name of the Holder, this Warrant when surrendered for exercise shall be
      accompanied by the Assignment Form attached hereto duly executed by the Holder;
      and the Company may require, as a condition thereto, the payment of a sum
      sufficient to reimburse it for any transfer tax incidental thereto.

     

    6. Closing
      of Books.
      The
      Company will not close its stockholder books or records in any manner which
      prevents the timely exercise of this Warrant, pursuant to the terms
      hereof.

     

    7. Transfer,
      Division and Combination.
      

     

    (a) Subject
      to the transfer restrictions imposed by NASD Rule 2710(g) as set forth in the
      legend hereto, this Warrant and all rights hereunder are transferable, in whole
      or in part, upon surrender of this Warrant at the principal office of the
      Company, together with a written assignment of this Warrant substantially in
      the
      form attached hereto duly executed by the Holder or its agent or attorney and
      funds sufficient to pay any transfer taxes payable upon the making of such
      transfer. Upon such surrender and, if required, such payment, the Company shall
      execute and deliver a new Warrant or Warrants in the name of the assignee or
      assignees and in the denomination or denominations specified in such instrument
      of assignment, and shall issue to the assignor a new Warrant evidencing the
      portion of this Warrant not so assigned, and this Warrant shall promptly be
      cancelled. A Warrant, if properly assigned, may be exercised by a new holder
      for
      the purchase of Warrant Shares without having a new Warrant issued.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    (b) Subject
      to the transfer restrictions imposed by NASD Rule 2710(g) as set forth in the
      legend hereto, this Warrant may be divided or combined with other Warrants
      upon
      presentation hereof at the aforesaid office of the Company, together with a
      written notice specifying the names and denominations in which new Warrants
      are
      to be issued, signed by the Holder or its agent or attorney. Subject to
      compliance with Section 7(a), as to any transfer which may be involved in such
      division or combination, the Company shall execute and deliver a new Warrant
      or
      Warrants in exchange for the Warrant or Warrants to be divided or combined
      in
      accordance with such notice.

    

    (c) The
      Company shall prepare, issue and deliver at its own expense (other than transfer
      taxes) the new Warrant or Warrants under this Section 8.

    

    (d) The
      Company agrees to maintain, at its aforesaid office, books for the registration
      and the registration of transfer of the Warrants.

     

    8. Registration
      Rights.
      

     

    (a) Demand
      Registration.

     

    (i) Grant
      of Right.
      The
      Company, upon written demand (“Initial
      Demand Notice”)
      of the
      Holder(s) of at least 51% of the Warrants and/or the underlying shares of Common
      Stock (“Majority
      Holders”),
      agrees to register on one occasion, all or any portion of the Warrants requested
      by the Majority Holders in the Initial Demand Notice and all of the shares
      of
      Common Stock underlying such Warrants (collectively the “Registrable
      Securities”).
      On
      such occasion, the Company will file a registration statement covering the
      Registrable Securities within sixty (60) days after receipt of the Initial
      Demand Notice and use its best efforts to have the registration statement
      declared effective promptly thereafter. If the Company fails to comply with
      the
      provisions of this Section 8(a)(i), the Company shall, in addition to any other
      equitable or other relief available to the Holder(s), be liable for any and
      all
      incidental, special and consequential damages sustained by the Holder(s). The
      demand for registration may be made at any time during the five year period
      commencing after the closing of the Offering (“Closing”).
      The
      Company covenants and agrees to give written notice of its receipt of any
      Initial Demand Notice by any Holder(s) to all other registered Holders of the
      Warrants and/or the Registrable Securities within ten days from the date of
      the
      receipt of any such Initial Demand Notice.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    (ii) Terms.
      The
      Company shall bear all fees and expenses attendant to registering the
      Registrable Securities, but the Holders shall pay any and all underwriting
      commissions and the expenses of any legal counsel selected by the Holders to
      represent them in connection with the sale of the Registrable Securities. The
      Company agrees to use its best efforts to cause the filing required herein
      to
      become effective promptly and to qualify or register the Registrable Securities
      in such States as are reasonably requested by the Holder(s); provided, however,
      that in no event shall the Company be required to register the Registrable
      Securities in a State in which such registration would cause (a) the Company
      to
      be obligated to register or license to do business in such State or submit
      to
      general service of process in such State, or (b) the principal stockholders
      of
      the Company to be obligated to escrow their shares of capital stock of the
      Company. The Company shall cause any registration statement filed pursuant
      to
      the demand right granted under Section 8(a)(1) to remain effective for a period
      of at least twelve consecutive months from the date that the Holders of the
      Registrable Securities covered by such registration statement are first given
      the opportunity to sell all of such securities.

     

    (b) “Piggyback”
      Registration.

    

    (i) Grant
      of Right.
      In
      addition to the demand right of registration, the Holders of the Warants shall
      have the unlimited right during the five year period commencing after the
      Closing, to include the Registrable Securities as part of any other registration
      of securities filed by the Company (other than in connection with a transaction
      contemplated by Rule 145(a) promulgated under the Securities Act or pursuant
      to
      Form S-8 or any equivalent form) as long as such registration covers securities
      with a market value on the date of the initial filing of such registration
      statement in excess of $200,000; provided, however, that if, in the written
      determination of the Company's managing underwriter or underwriters, if any,
      for
      such offering, the inclusion of the Registrable Securities, when added to the
      securities being registered by the Company or the selling stockholder(s), will
      exceed the maximum amount of the Company's securities which can be marketed
      (a)
      at a price reasonably related to their then current market value, or (b) without
      materially and adversely affecting the entire offering, the Company shall
      nevertheless register all or any portion of the Registrable Securities required
      to be so registered but such Registrable Securities shall not be sold by the
      Holders until 90 days after the registration statement for such offering has
      become effective and provided further that, if any securities are registered
      for
      sale on behalf of other stockholders in such offering and such stockholders
      have
      not agreed to defer such sale until the expiration of such 90-day period, the
      number of securities to be sold by all stockholders in such public offering
      during such 90-day period shall be apportioned pro rata among all such selling
      stockholders, including all holders of the Registrable Securities, according
      to
      the total amount of securities of the Company owned by said selling
      stockholders, including all holders of the Registrable Securities.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    (ii) Terms.
      The
      Company shall bear all fees and expenses attendant to registering the
      Registrable Securities, but the Holders shall pay any and all underwriting
      commissions and the expenses of any legal counsel selected by the Holders to
      represent them in connection with the sale of the Registrable Securities. In
      the
      event of such a proposed registration, the Company shall furnish the then
      Holders of outstanding Registrable Securities with not less than thirty (30)
      days’ written notice prior to the proposed date of filing of such registration
      statement. Such notice to the Holders shall continue to be given for each
      registration statement filed by the Company until such time as all of the
      Registrable Securities have been sold by the Holder. The holders of the
      Registrable Securities shall exercise the “piggyback” rights provided for herein
      by giving written notice within twenty (20) days of the receipt of the Company's
      notice of its intention to file a registration statement. The Company shall
      cause any registration statement filed pursuant to the above “piggyback” rights
      to remain effective for at least twelve months from the date that the Holders
      of
      the Registrable Securities are first given the opportunity to sell all of such
      securities. The demand and “piggyback” rights set forth in this Section 8 shall
      cease at such time that the underlying shares of Common Stock are saleable
      under
      Rule 144(k) promulgated under the Securities Act.

     

    (c) General
      Terms.

    

    (i) Indemnification.
      The
      Company shall indemnify the Holder(s) of the Registrable Securities to be sold
      pursuant to any registration statement hereunder and each person, if any, who
      controls such Holders within the meaning of Section 15 of the Act or Section
      20(a) of the Securities Exchange Act of 1934, as amended (“Exchange
      Act”),
      against all loss, claim, damage, expense or liability (including all reasonable
      attorneys' fees and other expenses reasonably incurred in investigating,
      preparing or defending against any claim whatsoever) to which any of them may
      become subject under the Securities Act, the Exchange Act or otherwise, arising
      from such registration statement but only to the same extent and with the same
      effect as the provisions pursuant to which the Company has agreed to indemnify
      the underwriters (“Underwriters”)
      of the
      Offering contained in Section 6 of the underwriting agreement (“Underwriting
      Agreement”)
      between the Representatives of the Underwriters and the Company, dated the
      effective date of the Offering. The Holder(s) of the Registrable Securities
      to
      be sold pursuant to such registration statement, and their successors and
      assigns, shall severally, and not jointly, indemnify the Company against all
      loss, claim, damage, expense or liability (including all reasonable attorneys'
      fees and other expenses reasonably incurred in investigating, preparing or
      defending against any claim whatsoever) to which they may become subject under
      the Securities Act, the Exchange Act or otherwise, arising from information
      furnished by or on behalf of such Holders, or their successors or assigns,
      in
      writing, for specific inclusion in such registration statement to the same
      extent and with the same effect as the provisions contained in Section 6 of
      the
      Underwriting Agreement pursuant to which the underwriters have agreed to
      indemnify the Company.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    (ii) Exercise
      of Warrants.
      Nothing
      contained in this Warrant shall be construed as requiring the Holder(s) to
      exercise their Warrants prior to or after the initial filing of any registration
      statement or the effectiveness thereof.

     

    (iii) Documents
      Delivered to Holders.
      The
      Company shall furnish to each Holder participating in any of the foregoing
      offerings and to each underwriter of any such offering, if any, a signed
      counterpart, addressed to such Holder or underwriter, of (a) an opinion of
      counsel to the Company, dated the effective date of such registration statement
      (and, if such registration includes an underwritten public offering, an opinion
      dated the date of the closing under any underwriting agreement related thereto),
      and (b) a “cold comfort” letter dated the effective date of such registration
      statement (and, if such registration includes an underwritten public offering,
      a
      letter dated the date of the closing under the underwriting agreement) signed
      by
      the independent public accountants who have issued a report on the Company's
      financial statements included in such registration statement, in each case
      covering substantially the same matters with respect to such registration
      statement (and the prospectus included therein) and, in the case of such
      accountants' letter, with respect to events subsequent to the date of such
      financial statements, as are customarily covered in opinions of issuer's counsel
      and in accountants' letters delivered to underwriters in underwritten public
      offerings of securities. The Company shall also deliver promptly to each Holder
      participating in the offering requesting the correspondence and memoranda
      described below and to the managing underwriter copies of all correspondence
      between the Commission and the Company, its counsel or auditors and all
      memoranda relating to discussions with the Commission or its staff with respect
      to the registration statement and permit each Holder and underwriter to do
      such
      investigation, upon reasonable advance notice, with respect to information
      contained in or omitted from the registration statement as it deems reasonably
      necessary to comply with applicable securities laws or rules of FINRA. Such
      investigation shall include access to books, records and properties and
      opportunities to discuss the business of the Company with its officers and
      independent auditors, all to such reasonable extent and at such reasonable
      times
      as any such Holder shall reasonably request.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    (iv) Underwriting
      Agreement.
      The
      Company shall enter into an underwriting agreement with the managing
      underwriter(s) selected by any Holders whose Registrable Securities are being
      registered pursuant to this Section 8, which managing underwriter shall be
      reasonably satisfactory to the Company. Such agreement shall be reasonably
      satisfactory in form and substance to the Company, each Holder and such managing
      underwriters, and shall contain such representations, warranties and covenants
      by the Company and such other terms as are customarily contained in agreements
      of that type used by the managing underwriter. The Holders shall be parties
      to
      any underwriting agreement relating to an underwritten sale of their Registrable
      Securities and may, at their option, require that any or all the
      representations, warranties and covenants of the Company to or for the benefit
      of such underwriters shall also be made to and for the benefit of such Holders.
      Such Holders shall not be required to make any representations or warranties
      to
      or agreements with the Company or the underwriters except as they may relate
      to
      such Holders, their shares and their intended methods of
      distribution.

     

    (v) Documents
      to Be Delivered by Holder(s).
      Each of
      the Holder(s) participating in any of the foregoing offerings shall furnish
      to
      the Company a completed and executed questionnaire provided by the Company
      requesting information customarily sought of selling
      securityholders.

     

    9. No
      Rights as Shareholder until Exercise.
      This
      Warrant does not entitle the Holder to any voting rights or other rights as
      a
      shareholder of the Company prior to the exercise hereof. Upon the surrender
      of
      this Warrant and the payment of the aggregate Exercise Price (or by means of
      a
      cashless exercise), the Warrant Shares so purchased shall be and be deemed
      to be
      issued to such Holder as the record owner of such shares as of the close of
      business on the later of the date of such surrender or payment. 

     

    10. Loss,
      Theft, Destruction or Mutilation of Warrant.
      The
      Company covenants that upon receipt by the Company of evidence reasonably
      satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
      or any stock certificate relating to the Warrant Shares, and in case of loss,
      theft or destruction, of indemnity or security reasonably satisfactory to it
      (which, in the case of the Warrant, shall not include the posting of any bond),
      and upon surrender and cancellation of such Warrant or stock certificate, if
      mutilated, the Company will make and deliver a new Warrant or stock certificate
      of like tenor and dated as of such cancellation, in lieu of such Warrant or
      stock certificate.

     

    11. Saturdays,
      Sundays, Holidays, etc.
      If the
      last or appointed day for the taking of any action or the expiration of any
      right required or granted herein shall be a Saturday, Sunday or a legal holiday,
      then such action may be taken or such right may be exercised on the next
      succeeding day not a Saturday, Sunday or legal holiday.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    12. Adjustments
      of Exercise Price and Number of Warrant Shares; Stock Splits,
      etc.
      The
      number and kind of securities purchasable upon the exercise of this Warrant
      and
      the Exercise Price shall be subject to adjustment from time to time upon the
      happening of any of the following. In case the Company shall (i) pay a dividend
      in shares of Common Stock or make a distribution in shares of Common Stock
      to
      holders of its outstanding Common Stock, (ii) subdivide its outstanding shares
      of Common Stock into a greater number of shares, (iii) combine its outstanding
      shares of Common Stock into a smaller number of shares of Common Stock, or
      (iv)
      issue any shares of its capital stock in a reclassification of the Common Stock,
      then the number of Warrant Shares purchasable upon exercise of this Warrant
      immediately prior thereto shall be adjusted so that the Holder shall be entitled
      to receive the kind and number of Warrant Shares or other securities of the
      Company which it would have owned or have been entitled to receive had such
      Warrant been exercised in advance thereof. Upon
      each
      such adjustment of the kind and number of Warrant Shares or other securities
      of
      the Company which are purchasable hereunder, the Holder shall thereafter be
      entitled to purchase the number of Warrant Shares or other securities resulting
      from such adjustment at an Exercise Price per Warrant Share or other security
      obtained by multiplying the Exercise Price in effect immediately prior to such
      adjustment by the number of Warrant Shares purchasable pursuant hereto
      immediately prior to such adjustment and dividing by the number of Warrant
      Shares or other securities of the Company resulting from such adjustment.
An
      adjustment made pursuant to this paragraph shall become effective immediately
      after the effective date of such event retroactive to the record date, if any,
      for such event. 

     

    13. Reorganization,
      Reclassification, Merger, Consolidation or Disposition of Assets.
      In case
      the Company shall reorganize its capital, reclassify its capital stock,
      consolidate or merge with or into another corporation (where the Company is
      not
      the surviving corporation or where there is a change in or distribution with
      respect to the Common Stock of the Company), or sell, transfer or otherwise
      dispose of all or substantially all its property, assets or business to another
      corporation and, pursuant to the terms of such reorganization, reclassification,
      merger, consolidation or disposition of assets, shares of common stock of the
      successor or acquiring corporation, or any cash, shares of stock or other
      securities or property of any nature whatsoever (including warrants or other
      subscription or purchase rights) in addition to or in lieu of common stock
      of
      the successor or acquiring corporation (“Other
      Property”),
      are
      to be received by or distributed to the holders of Common Stock of the Company,
      then the Holder shall have the right thereafter to receive, upon exercise of
      this Warrant, instead of the shares of Common Stock, the number of shares of
      common stock and/or Other Property receivable upon or as a result of such
      reorganization, reclassification, merger, consolidation or disposition of assets
      by a Holder of the number of shares of Common Stock for which this Warrant
      is
      exercisable immediately prior to such event. In case of any such reorganization,
      reclassification, merger, consolidation or disposition of assets, the successor
      or acquiring corporation (if other than the Company) shall expressly assume
      the
      due and punctual observance and performance of each and every covenant and
      condition of this Warrant to be performed and observed by the Company and all
      the obligations and liabilities hereunder, subject to such modifications as
      may
      be deemed appropriate (as determined in good faith by resolution of the Board
      of
      Directors of the Company) in order to provide for adjustments of Warrant Shares
      for which this Warrant is exercisable which shall be as nearly equivalent as
      practicable to the adjustments provided for in this Section 12. For purposes
      of
      this Section 12, “common stock” shall include stock of such corporation of any
      class which is not preferred as to dividends or assets over any other class
      of
      stock of such corporation and which is not subject to redemption and shall
      also
      include any evidences of indebtedness, shares of stock or other securities
      which
      are convertible into or exchangeable for any such stock, either immediately
      or
      upon the arrival of a specified date or the happening of a specified event
      and
      any warrants or other rights to subscribe for or purchase any such stock. The
      foregoing provisions of this Section 12 shall similarly apply to successive
      reorganizations, reclassifications, mergers, consolidations or disposition
      of
      assets. 

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    14. Voluntary
      Adjustment by the Company.
      The
      Company may at any time during the term of this Warrant reduce the then current
      Exercise Price to any amount and for any period of time deemed appropriate
      by
      the Board of Directors of the Company.

     

    15. Notice
      of Adjustment.
      Whenever the number of Warrant Shares or number or kind of securities or other
      property purchasable upon the exercise of this Warrant or the Exercise Price
      is
      adjusted, as herein provided, the Company shall give notice thereof to the
      Holder, which notice shall state the number of Warrant Shares (and other
      securities or property) purchasable upon the exercise of this Warrant and the
      Exercise Price of such Warrant Shares (and other securities or property) after
      such adjustment, setting forth a brief statement of the facts requiring such
      adjustment and setting forth the computation by which such adjustment was
      made.

     

    16. Notice
      of Corporate Action.
      If at
      any time:

     

    (a) the
      Company shall take a record of the holders of its Common Stock for the purpose
      of entitling them to receive an extraordinary dividend or other distribution,
      or
      any right to subscribe for or purchase any evidences of its indebtedness, any
      shares of stock of any class or any other securities or property, or to receive
      any other right, or

    

    (b) there
      shall be any capital reorganization of the Common Stock, any reclassification
      or
      recapitalization of the capital stock of the Company or any consolidation or
      merger of the Company with, or any sale, transfer or other disposition of all
      or
      substantially all the property, assets or business of the Company to, another
      corporation, or

    

    (c) there
      shall be a voluntary or involuntary dissolution, liquidation or winding up
      of
      the Company, or

    

    (d) no
      registration statement registering the sale of the Warrant Shares to the Holder
      upon exercise of this Warrant is then effective or such registration statement
      is not then available for use, as reasonably determined by the Company;

    

    

    then,
      in
      any one or more of such cases, the Company shall give to Holder (i) at least
      10
      days’ prior written notice of the date on which a record date shall be selected
      for such dividend, distribution or right or for determining rights to vote
      in
      respect of any such reorganization, reclassification, merger, consolidation,
      sale, transfer, disposition, liquidation or winding up, and (ii) in the case
      of
      any such reorganization, reclassification, merger, consolidation, sale,
      transfer, disposition, dissolution, liquidation or winding up, at least 10
      days’
prior written notice of the date when the same shall take place, and (iii)
      in
      the case of the absence of any effective registration statement registering
      the
      sale of the Warrant Shares to the Holder upon exercise of this Warrant or
      unavailability thereof, promptly upon knowledge by the Company of such
      occurrence. Such notice in accordance with the foregoing clauses (a)-(c) also
      shall specify (i) the date on which any such record is to be taken for the
      purpose of such dividend, distribution or right, the date on which the holders
      of Common Stock shall be entitled to any such dividend, distribution or right,
      and the amount and character thereof, and (ii) the date on which any such
      reorganization, reclassification, merger, consolidation, sale, transfer,
      disposition, dissolution, liquidation or winding up is to take place and the
      time, if any such time is to be fixed, as of which the holders of Common Stock
      shall be entitled to exchange their Warrant Shares for securities or other
      property deliverable upon such disposition, dissolution, liquidation or winding
      up. Such notice in accordance with clause (d) shall also specify the Company’s
      good faith believe as to when a registration statement registering such sale
      shall be filed or amended or available for use again. Each such written notice
      shall be sufficiently given if addressed to Holder at the last address of Holder
      appearing on the books of the Company and delivered in accordance with Section
      18(e).

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    17. Authorized
      Shares.
      The
      Company covenants that during the period the Warrant is outstanding, it will
      reserve from its authorized and unissued Common Stock a sufficient number of
      shares to provide for the issuance of the Warrant Shares upon the exercise
      of
      any purchase rights under this Warrant. The Company further covenants that
      its
      issuance of this Warrant shall constitute full authority to its officers who
      are
      charged with the duty of executing stock certificates to execute and issue
      the
      necessary certificates for the Warrant Shares upon the exercise of the purchase
      rights under this Warrant. The Company will take all such reasonable action
      as
      may be necessary to assure that such Warrant Shares may be issued as provided
      herein without violation of any applicable law or regulation, or of any
      requirements of the principal market or exchange upon which the Common Stock
      may
      be listed. 

     

    Except
      and to the extent as waived or consented to by the Holder, the Company shall
      not
      by any action, including, without limitation, amending its certificate of
      incorporation or through any reorganization, transfer of assets, consolidation,
      merger, dissolution, issue or sale of securities or any other voluntary action,
      avoid or seek to avoid the observance or performance of any of the terms of
      this
      Warrant, but will at all times in good faith assist in the carrying out of
      all
      such terms and in the taking of all such actions as may be necessary or
      appropriate to protect the rights of Holder as set forth in this Warrant against
      impairment. Without limiting the generality of the foregoing, the Company will
      (a) not increase the par value of any Warrant Shares above the amount payable
      therefor upon such exercise immediately prior to such increase in par value,
      (b)
      take all such action as may be necessary or appropriate in order that the
      Company may validly and legally issue fully paid and nonassessable Warrant
      Shares upon the exercise of this Warrant, and (c) use commercially reasonable
      efforts to obtain all such authorizations, exemptions or consents from any
      public regulatory body having jurisdiction thereof as may be necessary to enable
      the Company to perform its obligations under this Warrant.

    

    Before
      taking any action which would result in an adjustment in the number of Warrant
      Shares for which this Warrant is exercisable or in the Exercise Price, the
      Company shall obtain all such authorizations or exemptions thereof, or consents
      thereto, as may be necessary from any public regulatory body or bodies having
      jurisdiction thereof.

    

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    18. Miscellaneous.

     

    (a) Jurisdiction.
      This
      Warrant shall constitute a contract under the laws of New York, without regard
      to its conflict of law, principles or rules. The Company hereby agrees that
      any
      action, proceeding or claim against it arising out of, or relating in any way
      to
      this Warrant shall be brought and enforced in the courts of the State of New
      York or of the United States of America for the Southern District of New York,
      and irrevocably submits to such jurisdiction, which jurisdiction shall be
      exclusive. The Company hereby waives any objection to such exclusive
      jurisdiction and that such courts represent an inconvenient forum. Any process
      or summons to be served upon the Company may be served by transmitting a copy
      thereof by registered or certified mail, return receipt requested, postage
      prepaid, addressed to DLA Piper US LLP, 4365 Executive Drive, Suite 1100, San
      Diego, CA 92121, Attention: Doug Rein. Such mailing shall be deemed personal
      service and shall be legal and binding upon the Company in any action,
      proceeding or claim. The Company and the Holder, by acceptance hereof, agree
      that the prevailing party(ies) in any such action shall be entitled to recover
      from the other party(ies) all of its reasonable attorneys' fees and expenses
      relating to such action or proceeding and/or incurred in connection with the
      preparation therefor.

     

    (b) Restrictions.
      The
      Holder acknowledges that the Warrant Shares acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    (c) Nonwaiver
      and Expenses.
      No
      course of dealing or any delay or failure to exercise any right hereunder on
      the
      part of Holder shall operate as a waiver of such right or otherwise prejudice
      Holder’s rights, powers or remedies, notwithstanding all rights hereunder
      terminate on the Termination Date. If the Company willfully and knowingly fails
      to comply with any provision of this Warrant, which results in any material
      damages to the Holder, the Company shall pay to Holder such amounts as shall
      be
      sufficient to cover any costs and expenses including, but not limited to,
      reasonable attorneys’ fees, including those of appellate proceedings, incurred
      by Holder in collecting any amounts due pursuant hereto or in otherwise
      enforcing any of its rights, powers or remedies hereunder.

     

    (d) FINRA
      Rules.
      Notwithstanding anything contained in this Warrant, the terms of this Warrant
      are intended to comply with the rules and regulations of the Financial Industry
      Regulatory Authority, Inc. relating to the compensation of underwriters and
      placement agents, and any provision of this Warrant that is determined to be
      inconsistent with such rules shall be deemed to be modified to the extent
      necessary to comply with such rules.

     

    (e) Notices.
      All
      notices, requests, consents and other communications under this Warrant shall
      be
      in writing and shall be deemed to have been duly made on the date of delivery
      if
      delivered personally or sent by overnight courier, with acknowledgement of
      receipt to the party to which notice is given, or on the fifth day after mailing
      if mailed to the party to whom notice is to be given, by registered or certified
      mail, return receipt requested, postage prepaid and properly addressed as
      follows: (i) if to the registered Holder of the Warrant, to the address of
      such
      Holder as shown on the books of the Company, or (ii) if to the Company, to
      its
      principal executive office. Upon any permitted assignment of this Warrant,
      the
      assignee shall promptly provide the Company with its contact
      information.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

    (f) Limitation
      of Liability.
      No
      provision hereof, in the absence of any affirmative action by Holder to exercise
      this Warrant or purchase Warrant Shares, and no enumeration herein of the rights
      or privileges of Holder, shall give rise to any liability of Holder for the
      purchase price of any Common Stock or as a stockholder of the Company, whether
      such liability is asserted by the Company or by creditors of the
      Company.

     

    (g) Remedies.
      Holder,
      in addition to being entitled to exercise all rights granted by law, including
      recovery of damages, will be entitled to specific performance of its rights
      under this Warrant. The Company agrees that monetary damages would not be
      adequate compensation for any loss incurred by reason of a breach by it of
      the
      provisions of this Warrant and hereby agrees to waive the defense in any action
      for specific performance that a remedy at law would be adequate.

     

    (h) Successors
      and Assigns.
      Subject
      to applicable securities laws, this Warrant and the rights and obligations
      evidenced hereby shall inure to the benefit of and be binding upon the
      successors of the Company and the successors and permitted assigns of Holder.
      The provisions of this Warrant are intended to be for the benefit of all Holders
      from time to time of this Warrant and shall be enforceable by any such Holder
      or
      holder of Warrant Shares.

     

    (i) Amendment.
      This
      Warrant may be modified or amended or the provisions hereof waived with the
      written consent of the Company and the Holder; provided,
      however,
      if this
      Warrant is subsequently transferred to other Persons, this Warrant may be
      modified or amended or the provisions hereof waived with the written consent
      of
      such transferees (and the original Holder if such Holder holds any part of
      the
      Warrant at such time) holding Warrant(s) exercisable into a majority of the
      Warrant Shares then issuable under the Warrants derived from the initial
      Warrant. Notwithstanding anything to the contrary in this paragraph, the Company
      and the Underwriters may from time to time supplement or amend this Warant
      without the approval of any of the Holders in order to cure any ambiguity,
      to
      correct or supplement any provision contained herein which may be defective
      or
      inconsistent with any other provisions herein, or to make any other provisions
      in regard to matters or questions arising hereunder which the Company and the
      Underwriters may deem necessary or desirable and which the Company and the
      Underwriters deem shall not adversely affect the interest of the
      Holders.

     

    (j) Severability.
      Wherever possible, each provision of this Warrant shall be interpreted in such
      manner as to be effective and valid under applicable law, but if any provision
      of this Warrant shall be prohibited by or invalid under applicable law, such
      provision shall be ineffective to the extent of such prohibition or invalidity,
      without invalidating the remainder of such provisions or the remaining
      provisions of this Warrant.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

    (k) Headings.
      The
      headings used in this Warrant are for the convenience of reference only and
      shall not, for any purpose, be deemed a part of this Warrant.

     

    ********************

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
      officer thereunto duly authorized.

    

    Dated:
      ______ __, 2008

     

    
      	 	 	 
	 	HUIHENG MEDICAL,
              INC.
	 
 	 
 	 
 
	 	By:  	 
	 	
              

              Name:
                Hui Xiaobing

              Title:
                Chief Executive Officer

            

    

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    NOTICE
      OF EXERCISE

    

    To: Huiheng
      Medical, Inc.

    

    (1) The
      undersigned hereby elects to purchase ________ Warrant Shares of Huiheng
      Medical, Inc. pursuant to the terms of the attached Warrant (only if exercised
      in full), and tenders herewith payment of the exercise price in full, together
      with all applicable transfer taxes, if any.

     

    (2) Please
      issue a certificate or certificates representing said Warrant Shares in the
      name
      of the undersigned or in such other name as is specified below:

     

    
      
 

     

    

    The
      Warrant Shares shall be delivered to the following DTC account:

    

    
      
 

    
      
 

    
      
 

     

    
      	 	 	 
	 	[Holder]
	 
 	 
 	 
 
	 	By:  	 
	 	
              

              Name:

              Title:

            
	 	 

      	 	 Dated:
              	 

              

            

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

    

     

    ASSIGNMENT
      FORM

    

    (To
      assign the foregoing warrant, execute

    this
      form
      and supply required information. 

    Do
      not
      use this form to exercise the warrant.)

    

    

    

    FOR
      VALUE
      RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
      assigned to

     

    

    _______________________________________________
      whose address is

    

    _______________________________________________________________.

    

    

    

    _______________________________________________________________

    

    Dated:
      ______________, _______

    

    

    Holder's
      Signature: _____________________________

    

    Holder's
      Address: _____________________________

     

    _____________________________

    

    

    

    Signature
      Guaranteed: ___________________________________________

    

    

    NOTE:
      The
      signature to this Assignment Form must correspond with the name as it appears
      on
      the face of the Warrant, without alteration or enlargement or any change
      whatsoever, and must be guaranteed by a bank or trust company. Officers of
      corporations and those acting in a fiduciary or other representative capacity
      should file proper evidence of authority to assign the foregoing
      Warrant.

    

     

    17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]